Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Larisa Kostousov"'
Autor:
Sharia D. Hernandez, Wei Lu, Alejandra G. Serrano, Claudio J. Arrechedera, Beatriz Sanchez-Espiridion, Nejla Ozirmak, Max Molina, Larisa Kostousov, Sean Barnes, Khaja Khan, Ximing Tang, Junya Fujimoto, Edwin R. Parra, Gabriela Raso, Stephanie T. Schmidt, Carmen Behrens, John Heymach, Jianjun Zhang, Ken Chen, Boris Sepesi, Tina Cascone, Don Gibbons, Ignacio I. Wistuba, Cara Haymaker, Luisa M. Solis
Publikováno v:
Cancer Research. 83:4460-4460
Background: Recently, neoadjuvant immunotherapy plus chemotherapy has been approved for treatment of resectable non-small cell lung carcinoma (NSCLC). Defining the immune landscape of these tumors and its spatial distribution will help to understand
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2a4564b4e215764a62bf5a7b0fbf3b8f
https://doi.org/10.1158/1538-7445.am2023-4460
https://doi.org/10.1158/1538-7445.am2023-4460
Autor:
Sharia Hernandez, Prajnan Das, Emma B. Holliday, Li Shen, Wei Lu, Benny Johnson, Craig A. Messick, Cullen M. Taniguchi, John Skibber, Ethan B. Ludmir, Y. Nancy You, Grace Li Smith, Brian Bednarski, Larisa Kostousov, Eugene J. Koay, Bruce D. Minsky, Matthew Tillman, Shaelynn Portier, Cathy Eng, Albert C. Koong, George J. Chang, Wai Chin Foo, Jing Wang, Luisa Solis Soto, Van K. Morris
Publikováno v:
Cancers; Volume 15; Issue 6; Pages: 1701
The identification of transcriptomic and protein biomarkers prognosticating recurrence risk after chemoradiation of localized squamous cell carcinoma of the anus (SCCA) has been limited by a lack of available fresh tissue at initial presentation. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1b54f999cf6c512f04ed4be45af49ff
https://doi.org/10.3390/cancers15061701
https://doi.org/10.3390/cancers15061701
Publikováno v:
Journal of Thrombosis and Thrombolysis. 40:437-443
Endoluminal devices such as metallic flow diversion (FD) and aneurysm bridging (AB) stents are used for treatment of intracranial aneurysms. Treatments are associated with thrombogenic events mandating the use of dual antiplatelet therapy in all case
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::357ed1c3351c4d63002ece2ae8d611fe
https://doi.org/10.1007/s11239-015-1228-0
https://doi.org/10.1007/s11239-015-1228-0